Rather than producing medicines through batch-wise, step-by-step processes, CONTINUUS Pharmaceuticals offers a breakthrough Integrated Continuous Manufacturing (ICM) technology for small molecule pharmaceuticals.
CONTINUUS Pharmaceuticals is leveraging the experience, know-how, and novel process technologies developed at the Novartis-MIT Center for Continuous Manufacturing to advance the state of manufacturing within the pharmaceutical industry. It is our vision that, through our advanced technology platform, we can help innovator and generic drug companies develop and manufacture higher quality drugs in a more efficient and cost-effective manner. Our product offerings are tailored to provide clients with the best solutions for their pharmaceutical development and manufacturing needs. They include the following:
These product offerings provide clients with a range of opportunities with varying risk-reward profiles. Targeted solutions will help clients solve specific challenges encountered with current batch processes, while implementation of ICM lines will completely transform their manufacturing platforms. Figure 1 illustrates these opportunities.
Figure 1. CONTINUUS Pharmaceuticals Offers a Range of Product Offerings